› Forums › General Melanoma Community › Next Step
- This topic has 69 replies, 12 voices, and was last updated 9 years, 2 months ago by
debwray.
- Post
-
- January 3, 2017 at 4:31 pm
Even though the doctors are telling me there's still some hope that the TIL might work I'm looking at the reality of the numbers. I only received a yield of 15 billion cells, which is only 1/10 or less of the normal. I was only receive able to receive three bags of IL-2 out of 14. This hospital has never stopped before five.
The doctors haven't told me any decent survival numbers for a long time. I'm insisting this morning that they come and talk to me. I need them to tell me when things are going to happen like liver failure etc. and a realistic expectation of when I'm going die if the IL-2 fails.
I have to wait six weeks for the next scan. Frankly I am not happy to just sit tight and wait and watch for six weeks. That's a lot of valuable time.
So here are my thoughts about my next Plan B. It seems to me that my cancer has mutated such that it is no longer susceptible to the two big pathways that everybody has been targeting. Namely CTLA-4 and PD-1. My cancer really seemed to go nuts while on the Atezolizumab and OX-40 trial, so I'm not interested in anymore OX-40.
I remember watching a video from Dr. Hamid that Ed posted a link to, talking about a treatment they had for people with heavily treated tumors but I cannot find it.
So my melanoma family, what do you all think?
– Paul
- Replies
-
-
- January 3, 2017 at 5:10 pm
-
- January 3, 2017 at 5:10 pm
-
- January 3, 2017 at 5:10 pm
-
- January 3, 2017 at 5:10 pm
-
- January 3, 2017 at 5:10 pm
-
- January 3, 2017 at 5:10 pm
-
- January 3, 2017 at 6:57 pm
Hi Paul,
I hear what you are saying re the lower number than hoped for TILs and the lower number of IL2 treatments. The stats only give us the likely odds- and it may just be that you will fall the other side of the line rather than the one you currently expect.
This gives a list of the early stage trials in the states. https://clinicaltrials.gov/ct2/results?term=melanoma&recr=Open&cntry1=NA%3AUS&age=1&phase=04&pg=2
Not sure if there might be anything that is worth looking in to ?
Have also heard a bit about tumour sequencing in the lab then bench testing other cancer drugs to check for response before deciding on personalised prescribing for an individual- sort of shortening the odds of getting a better hit rate.
Not sure if this is the video link you were looking for… but it is Dr Hamid and goes into some detail but is a bit old now as 2014 https://www.youtube.com/watch?v=UKwuLmhT3Is.. but it might let you surf to something more relevant. to your current position.
Bet you find that the docs are reluctant to have too detailed a conversation about the future- I think it may be because they deal with a wide range of rates of disease progression and because so many factors come in to play…you might be able to pin them down on what might be a rapid progression window with little response to the TIL treatment or an average type response… Wouldn't be suprised if they said we will be able to have a better conversation after the scan..but like you say that is six precious weeks away.
best wishes
Deb
-
- January 4, 2017 at 1:04 pm
Thanks Deb,
I am still hopeful to get some benefit from the TIL but I am not willing to bet the entire farm on it.
I am scheduling an appointment with my regular melanoma oncologist. He is a straight shooter and I trust him the most. Hopefully he will give me a worst-case estimate.
– Paul
-
- January 4, 2017 at 10:01 pm
Glad to see you are pulling together the threads for plan B .Tried to find that email but only got the office numbers/ twitter account. You can work out which conferences Dr Hamid will be speaking at soon though…via twitter. https://twitter.com/omidhamidmd?lang=en
-
- January 4, 2017 at 10:01 pm
Glad to see you are pulling together the threads for plan B .Tried to find that email but only got the office numbers/ twitter account. You can work out which conferences Dr Hamid will be speaking at soon though…via twitter. https://twitter.com/omidhamidmd?lang=en
-
- January 4, 2017 at 10:01 pm
Glad to see you are pulling together the threads for plan B .Tried to find that email but only got the office numbers/ twitter account. You can work out which conferences Dr Hamid will be speaking at soon though…via twitter. https://twitter.com/omidhamidmd?lang=en
-
- January 4, 2017 at 1:04 pm
Thanks Deb,
I am still hopeful to get some benefit from the TIL but I am not willing to bet the entire farm on it.
I am scheduling an appointment with my regular melanoma oncologist. He is a straight shooter and I trust him the most. Hopefully he will give me a worst-case estimate.
– Paul
-
- January 4, 2017 at 1:04 pm
Thanks Deb,
I am still hopeful to get some benefit from the TIL but I am not willing to bet the entire farm on it.
I am scheduling an appointment with my regular melanoma oncologist. He is a straight shooter and I trust him the most. Hopefully he will give me a worst-case estimate.
– Paul
-
- January 3, 2017 at 6:57 pm
Hi Paul,
I hear what you are saying re the lower number than hoped for TILs and the lower number of IL2 treatments. The stats only give us the likely odds- and it may just be that you will fall the other side of the line rather than the one you currently expect.
This gives a list of the early stage trials in the states. https://clinicaltrials.gov/ct2/results?term=melanoma&recr=Open&cntry1=NA%3AUS&age=1&phase=04&pg=2
Not sure if there might be anything that is worth looking in to ?
Have also heard a bit about tumour sequencing in the lab then bench testing other cancer drugs to check for response before deciding on personalised prescribing for an individual- sort of shortening the odds of getting a better hit rate.
Not sure if this is the video link you were looking for… but it is Dr Hamid and goes into some detail but is a bit old now as 2014 https://www.youtube.com/watch?v=UKwuLmhT3Is.. but it might let you surf to something more relevant. to your current position.
Bet you find that the docs are reluctant to have too detailed a conversation about the future- I think it may be because they deal with a wide range of rates of disease progression and because so many factors come in to play…you might be able to pin them down on what might be a rapid progression window with little response to the TIL treatment or an average type response… Wouldn't be suprised if they said we will be able to have a better conversation after the scan..but like you say that is six precious weeks away.
best wishes
Deb
-
- January 3, 2017 at 6:57 pm
Hi Paul,
I hear what you are saying re the lower number than hoped for TILs and the lower number of IL2 treatments. The stats only give us the likely odds- and it may just be that you will fall the other side of the line rather than the one you currently expect.
This gives a list of the early stage trials in the states. https://clinicaltrials.gov/ct2/results?term=melanoma&recr=Open&cntry1=NA%3AUS&age=1&phase=04&pg=2
Not sure if there might be anything that is worth looking in to ?
Have also heard a bit about tumour sequencing in the lab then bench testing other cancer drugs to check for response before deciding on personalised prescribing for an individual- sort of shortening the odds of getting a better hit rate.
Not sure if this is the video link you were looking for… but it is Dr Hamid and goes into some detail but is a bit old now as 2014 https://www.youtube.com/watch?v=UKwuLmhT3Is.. but it might let you surf to something more relevant. to your current position.
Bet you find that the docs are reluctant to have too detailed a conversation about the future- I think it may be because they deal with a wide range of rates of disease progression and because so many factors come in to play…you might be able to pin them down on what might be a rapid progression window with little response to the TIL treatment or an average type response… Wouldn't be suprised if they said we will be able to have a better conversation after the scan..but like you say that is six precious weeks away.
best wishes
Deb
-
- January 3, 2017 at 7:37 pm
Hi Paul, here is a link to the Angeles Clinic where dr. Omid Hamid works out of with a list of trials that are going on there.http://www.theangelesclinic.org/Home/ResearchClinicalTrials/ClinicalTrialList/tabid/19278/Default.aspx
There are two companies that have new drugs in the pipeline that might be of some help. Genentech and Incyte. https://www.gene.com/medical-professionals/pipeline and second link http://www.incyte.com/ir/press-releases.aspx look at press releases with incyte home page and what we do drop down box, then click on develop. Best Wishes!!!Ed
-
- January 3, 2017 at 7:37 pm
Hi Paul, here is a link to the Angeles Clinic where dr. Omid Hamid works out of with a list of trials that are going on there.http://www.theangelesclinic.org/Home/ResearchClinicalTrials/ClinicalTrialList/tabid/19278/Default.aspx
There are two companies that have new drugs in the pipeline that might be of some help. Genentech and Incyte. https://www.gene.com/medical-professionals/pipeline and second link http://www.incyte.com/ir/press-releases.aspx look at press releases with incyte home page and what we do drop down box, then click on develop. Best Wishes!!!Ed
-
- January 3, 2017 at 7:37 pm
Hi Paul, here is a link to the Angeles Clinic where dr. Omid Hamid works out of with a list of trials that are going on there.http://www.theangelesclinic.org/Home/ResearchClinicalTrials/ClinicalTrialList/tabid/19278/Default.aspx
There are two companies that have new drugs in the pipeline that might be of some help. Genentech and Incyte. https://www.gene.com/medical-professionals/pipeline and second link http://www.incyte.com/ir/press-releases.aspx look at press releases with incyte home page and what we do drop down box, then click on develop. Best Wishes!!!Ed
-
- January 4, 2017 at 12:41 am
You mentioned your liver. Can you have stereotactic body radiation therapy? It’s like gamma knife for soft tissue and there is evidence of this working on melanoma patients with immunotherapy. Maybe this could be helpful now.You need a expert.
-
- January 4, 2017 at 1:35 am
Hey Paul,
I just want you to know you're in my thoughts and prayers. Hoping that something will work out asap.
Terrie
-
- January 4, 2017 at 4:42 am
I am sure Celeste will chime in here with some great thoughts. I am such a newbie to all of this, I don't have much to offer. I to was wondering if radiation was an option? What about chemo? Or have you done that?
I feel so heartbroken for those of you that are fighting so hard and reaching dead ends. I think about Josh and you every day. Please keep fighting, you never know what is going to work.
xo Jen
-
- January 4, 2017 at 4:42 am
I am sure Celeste will chime in here with some great thoughts. I am such a newbie to all of this, I don't have much to offer. I to was wondering if radiation was an option? What about chemo? Or have you done that?
I feel so heartbroken for those of you that are fighting so hard and reaching dead ends. I think about Josh and you every day. Please keep fighting, you never know what is going to work.
xo Jen
-
- January 4, 2017 at 4:42 am
I am sure Celeste will chime in here with some great thoughts. I am such a newbie to all of this, I don't have much to offer. I to was wondering if radiation was an option? What about chemo? Or have you done that?
I feel so heartbroken for those of you that are fighting so hard and reaching dead ends. I think about Josh and you every day. Please keep fighting, you never know what is going to work.
xo Jen
-
- January 4, 2017 at 11:19 am
Hi Paul,
Is there an option to do some low-dose IL-2 for a couple of weeks. When my husband did TIL it was part of a trial with a high-dose arm and a low–dose arm for the IL-2 part. Typically high dose has been used with TIL but they are hoping to get good evidence that the low dose is effective and this is much more tolerable. It was a daily injection done at home for second week. The IL-2 is supposed to help the T-cells multiply etc as far as I understand it. Our big challenge was that there were only 4 billion T-cells produced for my husband, very unlucky, but I still think the whole process bought us time and held back further new mets, etc.
Also, T-cells take their time to work, it is a gradual response and if you could get going on something else then it may all contribute together to helping you. I know you have lots of great advice on possible next steps. We are going to be needing something new also.
Thinking of you
Maria
-
- January 4, 2017 at 6:55 pm
Hi Maria,
My yield was disappointingly low too, at only 16 billion cells. The TIL is part of a trial, which have strict protocols, so low dose IL-2 would be off shelf at this point.
I will continue to keep posting updates. I wish Josh would give us an update but I understand he wants to make family time top priority.
– Paul
-
- January 4, 2017 at 6:55 pm
Hi Maria,
My yield was disappointingly low too, at only 16 billion cells. The TIL is part of a trial, which have strict protocols, so low dose IL-2 would be off shelf at this point.
I will continue to keep posting updates. I wish Josh would give us an update but I understand he wants to make family time top priority.
– Paul
-
- January 4, 2017 at 6:55 pm
Hi Maria,
My yield was disappointingly low too, at only 16 billion cells. The TIL is part of a trial, which have strict protocols, so low dose IL-2 would be off shelf at this point.
I will continue to keep posting updates. I wish Josh would give us an update but I understand he wants to make family time top priority.
– Paul
-
- January 4, 2017 at 11:19 am
Hi Paul,
Is there an option to do some low-dose IL-2 for a couple of weeks. When my husband did TIL it was part of a trial with a high-dose arm and a low–dose arm for the IL-2 part. Typically high dose has been used with TIL but they are hoping to get good evidence that the low dose is effective and this is much more tolerable. It was a daily injection done at home for second week. The IL-2 is supposed to help the T-cells multiply etc as far as I understand it. Our big challenge was that there were only 4 billion T-cells produced for my husband, very unlucky, but I still think the whole process bought us time and held back further new mets, etc.
Also, T-cells take their time to work, it is a gradual response and if you could get going on something else then it may all contribute together to helping you. I know you have lots of great advice on possible next steps. We are going to be needing something new also.
Thinking of you
Maria
-
- January 4, 2017 at 11:19 am
Hi Paul,
Is there an option to do some low-dose IL-2 for a couple of weeks. When my husband did TIL it was part of a trial with a high-dose arm and a low–dose arm for the IL-2 part. Typically high dose has been used with TIL but they are hoping to get good evidence that the low dose is effective and this is much more tolerable. It was a daily injection done at home for second week. The IL-2 is supposed to help the T-cells multiply etc as far as I understand it. Our big challenge was that there were only 4 billion T-cells produced for my husband, very unlucky, but I still think the whole process bought us time and held back further new mets, etc.
Also, T-cells take their time to work, it is a gradual response and if you could get going on something else then it may all contribute together to helping you. I know you have lots of great advice on possible next steps. We are going to be needing something new also.
Thinking of you
Maria
-
- January 4, 2017 at 12:42 pm
I found several recent U Tube interviews with Dr. Hamid who says he is particularly interested in patients that have progressed on front line immunotherapy treatment. He goes on to say that they have been getting great response rates 50-70% in some of their trials for such patients.
So I completed the new patient request form including a brief history. If anyone knows Dr. Hamid's email, it would be awesome.
Living out of a hotel for however long will suck, but that still beats dead.
Besides, I will have an entirely new crew of nurses to help me refine my morbid sense of humor. Muah hah hah.
– Paul
-
- January 4, 2017 at 3:21 pm
Hi Paul, just phone # of clinic from web 310-582-7900 . I follow him on twitter @omidHamidMD Best of luck!!!Ed
-
- January 4, 2017 at 3:21 pm
Hi Paul, just phone # of clinic from web 310-582-7900 . I follow him on twitter @omidHamidMD Best of luck!!!Ed
-
- January 4, 2017 at 3:21 pm
Hi Paul, just phone # of clinic from web 310-582-7900 . I follow him on twitter @omidHamidMD Best of luck!!!Ed
-
- January 4, 2017 at 12:42 pm
I found several recent U Tube interviews with Dr. Hamid who says he is particularly interested in patients that have progressed on front line immunotherapy treatment. He goes on to say that they have been getting great response rates 50-70% in some of their trials for such patients.
So I completed the new patient request form including a brief history. If anyone knows Dr. Hamid's email, it would be awesome.
Living out of a hotel for however long will suck, but that still beats dead.
Besides, I will have an entirely new crew of nurses to help me refine my morbid sense of humor. Muah hah hah.
– Paul
-
- January 4, 2017 at 12:42 pm
I found several recent U Tube interviews with Dr. Hamid who says he is particularly interested in patients that have progressed on front line immunotherapy treatment. He goes on to say that they have been getting great response rates 50-70% in some of their trials for such patients.
So I completed the new patient request form including a brief history. If anyone knows Dr. Hamid's email, it would be awesome.
Living out of a hotel for however long will suck, but that still beats dead.
Besides, I will have an entirely new crew of nurses to help me refine my morbid sense of humor. Muah hah hah.
– Paul
-
- January 4, 2017 at 2:07 pm
Hey Paul,
I've been quickly reading up on the CTLA-4 pathway and I know IPI wasn't successful for you so I ran across this from Dr. Hodi at Dana-Farber. I'm still trying to wrap my brain around all this so take anything I say with a "research grain of salt". And this has been mentioned several times in the last couple of months which is Avastin as an add-on (there are even studies with Avastin and IL-2 together): From Dr. Hodi "In 2014 he published a study showing that patients with high blood levels of the protein VEGF tend to have a poor response to ipilimumab. The findings suggest that such patients may benefit from regimens that combine checkpoint inhibitors like ipilimumab with VEGF-blocking agents such as bevacizumab (Avastin®). Hodi’s team has launched a clinical trial of this combination in patients with advanced melanoma." I'm trying to find out more on bevacizumab as therapy alone since you've done IPI. But thought maybe in the interim as you are figuring out Plan B. I wish I had more! Many hugs.
I know you aren't a huge fan of clinical speak so I'm pasting one conclusion from one of the studies regarding Avastin: Conclusion "Bevacizumab monotherapy demonstrated promising clinical efficacy in patients with metastatic melanoma with disease control in 31% of the patients. Induced early hypertension was a marker for clinical efficacy of bevacizumab."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376108/
It can maybe be added on??
I'll let others chime in since I'm not sure of any of this is relavant.
Here was an earlier discussion on the board about it last year:
-
- January 4, 2017 at 2:07 pm
Hey Paul,
I've been quickly reading up on the CTLA-4 pathway and I know IPI wasn't successful for you so I ran across this from Dr. Hodi at Dana-Farber. I'm still trying to wrap my brain around all this so take anything I say with a "research grain of salt". And this has been mentioned several times in the last couple of months which is Avastin as an add-on (there are even studies with Avastin and IL-2 together): From Dr. Hodi "In 2014 he published a study showing that patients with high blood levels of the protein VEGF tend to have a poor response to ipilimumab. The findings suggest that such patients may benefit from regimens that combine checkpoint inhibitors like ipilimumab with VEGF-blocking agents such as bevacizumab (Avastin®). Hodi’s team has launched a clinical trial of this combination in patients with advanced melanoma." I'm trying to find out more on bevacizumab as therapy alone since you've done IPI. But thought maybe in the interim as you are figuring out Plan B. I wish I had more! Many hugs.
I know you aren't a huge fan of clinical speak so I'm pasting one conclusion from one of the studies regarding Avastin: Conclusion "Bevacizumab monotherapy demonstrated promising clinical efficacy in patients with metastatic melanoma with disease control in 31% of the patients. Induced early hypertension was a marker for clinical efficacy of bevacizumab."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376108/
It can maybe be added on??
I'll let others chime in since I'm not sure of any of this is relavant.
Here was an earlier discussion on the board about it last year:
-
- January 4, 2017 at 2:07 pm
Hey Paul,
I've been quickly reading up on the CTLA-4 pathway and I know IPI wasn't successful for you so I ran across this from Dr. Hodi at Dana-Farber. I'm still trying to wrap my brain around all this so take anything I say with a "research grain of salt". And this has been mentioned several times in the last couple of months which is Avastin as an add-on (there are even studies with Avastin and IL-2 together): From Dr. Hodi "In 2014 he published a study showing that patients with high blood levels of the protein VEGF tend to have a poor response to ipilimumab. The findings suggest that such patients may benefit from regimens that combine checkpoint inhibitors like ipilimumab with VEGF-blocking agents such as bevacizumab (Avastin®). Hodi’s team has launched a clinical trial of this combination in patients with advanced melanoma." I'm trying to find out more on bevacizumab as therapy alone since you've done IPI. But thought maybe in the interim as you are figuring out Plan B. I wish I had more! Many hugs.
I know you aren't a huge fan of clinical speak so I'm pasting one conclusion from one of the studies regarding Avastin: Conclusion "Bevacizumab monotherapy demonstrated promising clinical efficacy in patients with metastatic melanoma with disease control in 31% of the patients. Induced early hypertension was a marker for clinical efficacy of bevacizumab."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376108/
It can maybe be added on??
I'll let others chime in since I'm not sure of any of this is relavant.
Here was an earlier discussion on the board about it last year:
-
- January 4, 2017 at 4:20 pm
Hey Paulster!!
I don't blame you for being very forward thinking. I pretty much put all my current eggs in the basket of this post (includes a link within to my prior list, as well as one in which Weber talks about future combo's in melanoma, and a report that includes info on VISTA): http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2016/12/more-trial-options-for-those-who-have.html
If I were in your shoes I would certainly be giving the combo of PD-L1, PD-L2 and VISTA antagonists a hard look (it's being offered in San Fran!!!!) as well as the NCI match trial where they test your tumor for anything and everything it might respond to, like meds typically used to treat breast cancer and such.
Dr Hamid is certainly a melanoma Big Dog with a great reputation. Additionally, from all reports that I have heard, an incredible human.
Hang in there. Keep pushing. Much love, c
-
- January 4, 2017 at 4:20 pm
Hey Paulster!!
I don't blame you for being very forward thinking. I pretty much put all my current eggs in the basket of this post (includes a link within to my prior list, as well as one in which Weber talks about future combo's in melanoma, and a report that includes info on VISTA): http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2016/12/more-trial-options-for-those-who-have.html
If I were in your shoes I would certainly be giving the combo of PD-L1, PD-L2 and VISTA antagonists a hard look (it's being offered in San Fran!!!!) as well as the NCI match trial where they test your tumor for anything and everything it might respond to, like meds typically used to treat breast cancer and such.
Dr Hamid is certainly a melanoma Big Dog with a great reputation. Additionally, from all reports that I have heard, an incredible human.
Hang in there. Keep pushing. Much love, c
-
- January 4, 2017 at 4:20 pm
Hey Paulster!!
I don't blame you for being very forward thinking. I pretty much put all my current eggs in the basket of this post (includes a link within to my prior list, as well as one in which Weber talks about future combo's in melanoma, and a report that includes info on VISTA): http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2016/12/more-trial-options-for-those-who-have.html
If I were in your shoes I would certainly be giving the combo of PD-L1, PD-L2 and VISTA antagonists a hard look (it's being offered in San Fran!!!!) as well as the NCI match trial where they test your tumor for anything and everything it might respond to, like meds typically used to treat breast cancer and such.
Dr Hamid is certainly a melanoma Big Dog with a great reputation. Additionally, from all reports that I have heard, an incredible human.
Hang in there. Keep pushing. Much love, c
-
- January 4, 2017 at 5:51 pm
Dear Paul,
I am from the pray and support team here, don't know anything really about treatments available, but know that you are on our minds, we pray and believe in you getting better!
You are strong and smart and full of life, you will find something great and beat this thing…
Love,
Patrisa
-
- January 4, 2017 at 5:51 pm
Dear Paul,
I am from the pray and support team here, don't know anything really about treatments available, but know that you are on our minds, we pray and believe in you getting better!
You are strong and smart and full of life, you will find something great and beat this thing…
Love,
Patrisa
-
- January 4, 2017 at 5:51 pm
Dear Paul,
I am from the pray and support team here, don't know anything really about treatments available, but know that you are on our minds, we pray and believe in you getting better!
You are strong and smart and full of life, you will find something great and beat this thing…
Love,
Patrisa
-
- January 4, 2017 at 9:09 pm
Paul, first, I'm sorry to hear about the status of your TIL treatment. My thoughts–when I was at MDA in 2015, I was looking at a trial combining TIL with pembro. (I never got to the trial because my TIL cells didn't grow (they used a radiated tumor, so we knew the odds were low).) The theory of the trial is that PD-1 will help unmask the melanoma for the new TIL cells. Not sure what kind of results they are getting (they had only enrolled 1 patient as of November 2015). In any case, I wonder if you would benefit from adding PD-1. I don't think that I would assume that you're pre-and-post TIL immune systems are the "same". You may get some clinical benefit from PD-1. It may be too much (for your body) to also add ipi and chemo is probably counterproductive for the new TIL cells.
-
- January 4, 2017 at 9:09 pm
Paul, first, I'm sorry to hear about the status of your TIL treatment. My thoughts–when I was at MDA in 2015, I was looking at a trial combining TIL with pembro. (I never got to the trial because my TIL cells didn't grow (they used a radiated tumor, so we knew the odds were low).) The theory of the trial is that PD-1 will help unmask the melanoma for the new TIL cells. Not sure what kind of results they are getting (they had only enrolled 1 patient as of November 2015). In any case, I wonder if you would benefit from adding PD-1. I don't think that I would assume that you're pre-and-post TIL immune systems are the "same". You may get some clinical benefit from PD-1. It may be too much (for your body) to also add ipi and chemo is probably counterproductive for the new TIL cells.
-
- January 4, 2017 at 9:09 pm
Paul, first, I'm sorry to hear about the status of your TIL treatment. My thoughts–when I was at MDA in 2015, I was looking at a trial combining TIL with pembro. (I never got to the trial because my TIL cells didn't grow (they used a radiated tumor, so we knew the odds were low).) The theory of the trial is that PD-1 will help unmask the melanoma for the new TIL cells. Not sure what kind of results they are getting (they had only enrolled 1 patient as of November 2015). In any case, I wonder if you would benefit from adding PD-1. I don't think that I would assume that you're pre-and-post TIL immune systems are the "same". You may get some clinical benefit from PD-1. It may be too much (for your body) to also add ipi and chemo is probably counterproductive for the new TIL cells.
-
- You must be logged in to reply to this topic.